Department of Cardiovascular Sciences, European Hospital, Rome.
Catheter Cardiovasc Interv. 2014 Jan 1;83(1):70-7. doi: 10.1002/ccd.25054. Epub 2013 Jul 16.
To assess coronary plaque composition by virtual histology intravascular ultrasound (VH-IVUS) analysis in young adult recipients and to correlate these findings with time from heart transplant (HTx) and long-term outcomes.
Rapid progression of coronary allograft vasculopathy after heart transplantation is a powerful predictor of mortality and clinical events at long-term.
Forty consecutive young adult recipients transplanted during childhood undergoing VH-IVUS during coronary surveillance have been prospectively included in this study. According to the time interval from HTx to VH-IVUS assessment, our cohort was divided into two groups (group A: ≤5 years, n = 13; group B: >5 years, n = 27).
Group B showed an higher percentage of necrotic core and dense calcium (12 ± 2 vs. 5 ± 1%, P = 0.04; 8.2 vs. 2.1%, P = 0.03; respectively). An "inflammatory plaque" (necrotic core and dense calcium ≥30%) was detected in 34.8% of patients in group B and in none among group A patients (P = 0.03). Patients in group B had a number of adverse clinical events significantly higher than group A patients (53.8 vs. 14.3%; HR 4.45; 95% CI 1.62-12.16; P = 0.029) at long-term follow-up (4.2 years). The multivariate regression analysis showed that age (HR 1.5; 95% CI 1.1-2.0; P = 0.007), time from HTx (HR 1.8; 95% CI 1.6-4.8; P = 0.02), and inflammatory plaque (HR 2.4; 95% CI 1.1-5.3; P = 0.03) were independent predictors of adverse clinical events.
This study supports the hypothesis that time-dependent differences in plaque composition, as assessed by VH-IVUS, occur after HTx in young adult recipients, probably determining an increased risk of long-term clinical events.
通过虚拟组织学血管内超声(VH-IVUS)分析评估年轻成年心脏移植受者的冠状动脉斑块成分,并将这些发现与心脏移植(HTx)后时间和长期结果相关联。
心脏移植后冠状动脉移植物血管病的快速进展是死亡率和长期临床事件的有力预测因素。
本研究前瞻性纳入了 40 名在儿童时期接受心脏移植并在冠状动脉监测期间接受 VH-IVUS 检查的连续年轻成年受者。根据 HTx 至 VH-IVUS 评估的时间间隔,我们的队列分为两组(A 组:≤5 年,n=13;B 组:>5 年,n=27)。
B 组的坏死核心和致密钙百分比更高(12±2%比 5±1%,P=0.04;8.2%比 2.1%,P=0.03)。B 组 34.8%的患者存在“炎症斑块”(坏死核心和致密钙≥30%),而 A 组无一例患者存在(P=0.03)。B 组患者的不良临床事件发生率明显高于 A 组(53.8%比 14.3%;HR 4.45;95%CI 1.62-12.16;P=0.029),长期随访(4.2 年)。多变量回归分析显示,年龄(HR 1.5;95%CI 1.1-2.0;P=0.007)、HTx 后时间(HR 1.8;95%CI 1.6-4.8;P=0.02)和炎症斑块(HR 2.4;95%CI 1.1-5.3;P=0.03)是不良临床事件的独立预测因素。
这项研究支持这样一种假设,即 VH-IVUS 评估的斑块成分在年轻成年心脏移植受者中存在时间依赖性差异,可能导致长期临床事件风险增加。